6-N-[3-[(7-chloroquinolin-4-yl)amino]propyl]-2-N,4-N-bis(2-methylphenyl)-1,3,5-triazine-2,4,6-triamine | 1207449-73-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-N-[3-[(7-chloroquinolin-4-yl)amino]propyl]-2-N,4-N-bis(2-methylphenyl)-1,3,5-triazine-2,4,6-triamine
• CAS: 1207449-73-7
• 化学式: C₂₉H₂₉ClN₈
• 分子量: 525.056
• InChiKey: SJQFLNZNGACTSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.7
• 重原子数：
  38
• 可旋转键数：
  10
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  99.7
• 氢给体数：
  4
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  N-(7-chloroquinolin-4-yl)propane-1,3-diamine 、 6-chloro-N²,N⁴-di(2-methylphenyl)-1,3,5-triazine-2,4-diamine 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 生成 6-N-[3-[(7-chloroquinolin-4-yl)amino]propyl]-2-N,4-N-bis(2-methylphenyl)-1,3,5-triazine-2,4,6-triamine
  参考文献：
  名称：

  Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline–triazine conjugates

  摘要：

  A series of 4-aminoquinoline-triazine conjugates with different substitution pattern have been synthesized and evaluated for their in vitro antimalarial activity against chloroquine-sensitive and resistant strains of Plasmodium falciparum. Compounds 16, 19, 28 and 35 exhibited promising antimalarial activity against both strains of P. falciparum. Cytotoxicity of these compounds was tested against three cell lines. Several compounds did not show any cytotoxicity up to a high concentration (48 mu M), others exhibited mild toxicities but selective index for antimalarial activity was high for most of these conjugates. (c) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.10.106

文献信息

• AMINOQUINOLINE DERIVATIVES AND USES THEREOF
  申请人：THE MCLEAN HOSPITAL CORPORATION

  公开号：US20150023930A1

  公开（公告）日：2015-01-22

  Described herein are aminoquinoline and aminoacridine based hybrids, pharmaceutical compositions and medicaments that include such aminoquinoline and aminoacridine based hybrids, and methods of using such compounds for diagnosing and/or treating infections, neurodegerative diseases or disorders, inflammation, inflammation associated diseases and disorders, and/or diseases or disorders that are treatable with dopamine agonists such as the restless leg syndrome.

  本文描述了基于氨基喹啉和氨基蒽醌的混合物，包括含有这种基于氨基喹啉和氨基蒽醌的混合物的制药组合物和药物，以及使用这种化合物诊断和/或治疗感染、神经退行性疾病或障碍、炎症、与炎症相关的疾病和障碍以及可用多巴胺激动剂治疗的疾病或障碍（如不宁腿综合征）的方法。
• US9567316B2
  申请人：——

  公开号：US9567316B2

  公开（公告）日：2017-02-14